IC₅₀s data of antimalarials against controls. حسب Winnie Okore (14139712)

الموضوعات:

Drugs IC₅₀s data during the study period. حسب Winnie Okore (14139712)

الموضوعات:

SNPs IC₅₀s data at codon 876 during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Association of polymorphic IC_50s versus wild<i>-</i>type at codon 876 in selected drugs tested. حسب Winnie Okore (14139712)

الموضوعات:

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. حسب O’Llenecia S. Walker (8486163)

Number of samples per site during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Performance of selected drugs against field isolates during the study period. حسب Winnie Okore (14139712)

الموضوعات:

<i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period. حسب Winnie Okore (14139712)

الموضوعات:

<i>Pfmrp1</i> gene SNPs data during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period. حسب Winnie Okore (14139712)

الموضوعات:

<i>In vitro</i> 95% CI lower and upper mean susceptibility responses of field isolates to antimalarials. حسب Winnie Okore (14139712)

الموضوعات:

Performance of selected antimalarials against field isolates during the study period. حسب Winnie Okore (14139712)

الموضوعات:

Primers used for analysis of four SNPs in one gene. حسب Winnie Okore (14139712)

الموضوعات:

The decrease in blood flow disrupts CV pruning. حسب Lin Wen (557398)

Decrease in vRNA in brain during antiretroviral therapy. حسب Sonny R. Elizaldi (9684796)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…Here, we evaluated the aging and neurodegenerative effects of F-53B using the C. elegans model. After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…Here, we evaluated the aging and neurodegenerative effects of F-53B using the C. elegans model. After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…Here, we evaluated the aging and neurodegenerative effects of F-53B using the C. elegans model. After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations حسب Hui Li (32376)

"…Here, we evaluated the aging and neurodegenerative effects of F-53B using the C. elegans model. After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …"

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. حسب Narendran Gopalan (110148)